Evidence map›Paper›PMID 29438442›Full record

ArticlePloS one2018

The siRNA-mediated knockdown of GluN3A in 46C-derived neural stem cells affects mRNA expression levels of neural genes, including known iGluR interactors.

Svenja Pachernegg, Sebastian Eilebrecht, Elke Eilebrecht, Hendrik Schöneborn, Sebastian Neumann, Arndt G Benecke, Michael Hollmann

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Svenja PacherneggThe Florey Institute of Neuroscience and Mental Health, Parkville, Australia.ORCID 0000-0001-6555-9399
Sebastian EilebrechtCNRS UMR8246, Université Pierre et Marie Curie, Paris, France.
Elke EilebrechtFraunhofer Institute for Molecular Biology and Applied Ecology, Schmallenberg, Germany.
Hendrik SchönebornDepartment of Biochemistry II - Molecular Neurobiochemistry, Ruhr University Bochum, Bochum, Germany.
Sebastian NeumannDepartment of Biochemistry II - Molecular Biochemistry, Ruhr University Bochum, Bochum, Germany.
Arndt G BeneckeCNRS UMR8246, Université Pierre et Marie Curie, Paris, France.
Michael HollmannDepartment of Biochemistry I - Receptor Biochemistry, Ruhr University Bochum, Bochum, Germany.
Ruhr University Bochum · DECentre National de la Recherche Scientifique · FRFlorey Institute of Neuroscience and Mental Health · AUFraunhofer Institute for Molecular Biology and Applied Ecology · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For years, GluN3A was solely considered to be a dominant-negative modulator of NMDARs, since its incorporation into receptors alters hallmark features of conventional NMDARs composed of GluN1/GluN2 subunits. Only recently, increasing evidence has accumulated that GluN3A plays a more diversified role. It is considered to be critically involved in the maturation of glutamatergic synapses, and it might act as a molecular brake to prevent premature synaptic strengthening. Its expression pattern supports a putative role during neural development, since GluN3A is predominantly expressed in early pre- and postnatal stages. In this study, we used RNA interference to efficiently knock down GluN3A in 46C-derived neural stem cells (NSCs) both at the mRNA and at the protein level. Global gene expression profiling upon GluN3A knockdown revealed significantly altered expression of a multitude of neural genes, including genes encoding small GTPases, retinal proteins, and cytoskeletal proteins, some of which have been previously shown to interact with GluN3A or other iGluR subunits. Canonical pathway enrichment studies point at important roles of GluN3A affecting key cellular pathways involved in cell growth, proliferation, motility, and survival, such as the mTOR pathway. This study for the first time provides insights into transcriptome changes upon the specific knockdown of an NMDAR subunit in NSCs, which may help to identify additional functions and downstream pathways of GluN3A and GluN3A-containing NMDARs.

Indexed as

Gene Knockdown TechniquesAnimalsGene Expression ProfilingMiceNeural Stem CellsProtein BindingReceptors, N-Methyl-D-AspartateRNA, MessengerRNA, Small InterferingGluN3A protein, mouseReceptors, N-Methyl-D-AspartateRNA, MessengerRNA, Small Interfering

Identifiers

PMID29438442
PMCPMC5811004
OpenAlexW2788739394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.